Insider · CIK 0001999772
Margaret Pax
Files at RGEN (REPLIGEN CORP), ALIM (ALIMERA SCIENCES INC). First filing -, latest -.
In brief
Margaret Pax files SEC Form 4 as director at RGEN (REPLIGEN CORP), and also at ALIM (ALIMERA SCIENCES INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Margaret Pax has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 14, 2026 | RGEN REPLIGEN CORP | AGrant or award Common Stock | +995 | $0.00 | $0 | 3,011 | May 18, 2026 |
| May 14, 2026 | RGEN REPLIGEN CORP | AGrant or award Stock Option (Right to Buy)derivative | +2,239 | $0.00 | $0 | 2,239 | May 18, 2026 |
| May 15, 2025 | RGEN REPLIGEN CORP | AGrant or award Common Stock | +973 | $0.00 | $0 | 2,016 | May 19, 2025 |
| May 15, 2025 | RGEN REPLIGEN CORP | AGrant or award Stock Option (Right to Buy)derivative | +1,800 | $0.00 | $0 | 1,800 | May 19, 2025 |
| Nov 7, 2023 | ALIM ALIMERA SCIENCES INC | AGrant or award Stock Option (Right to Buy)derivative | +36,713 | $0.00 | $0 | 36,713 | Nov 8, 2023 |
Questions about Margaret Pax
Answered from the filings on this page, as of the latest one.
Is Margaret Pax buying or selling?
Margaret Pax has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Margaret Pax's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Margaret Pax has 0.
Where does Margaret Pax file Form 4?
Margaret Pax has filed Form 4 at RGEN (REPLIGEN CORP); ALIM (ALIMERA SCIENCES INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.